1. Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m 2. 2. Prevention of nausea and vomiting associated with initial and repeat course of moderately emetogenic cancer chemotherapy…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m 2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy…
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin >=50 mg/m. 1. 2 Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. 2…
Ondansetron is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2. initial and repeat courses of moderately emetogenic cancer…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.